Advanced company searchLink opens in new window

HALEON UK HOLDINGS (NO.2) LIMITED

Company number 11961650

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Sep 2024 PSC05 Change of details for Haleon Uk Holdings Limited as a person with significant control on 24 April 2019
11 Sep 2024 CS01 Confirmation statement made on 11 September 2024 with updates
11 Sep 2024 PSC05 Change of details for Haleon Intermediate Holdings Limited as a person with significant control on 15 December 2022
22 Aug 2024 AA Full accounts made up to 31 December 2023
20 Oct 2023 PSC05 Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 20 October 2023
17 Oct 2023 PSC05 Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 19 July 2022
03 Oct 2023 AA Full accounts made up to 31 December 2022
14 Sep 2023 CS01 Confirmation statement made on 14 September 2023 with updates
11 Sep 2023 TM01 Termination of appointment of Tobias Hannes Hestler as a director on 11 September 2023
16 Jun 2023 CERTNM Company name changed glaxosmithkline consumer healthcare holdings (no.2) LIMITED\certificate issued on 16/06/23
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2023-06-06
15 May 2023 CH02 Director's details changed for Haleon Uk Corporate Director Limited on 31 March 2023
15 May 2023 CH02 Director's details changed for Gsk Consumer Healthcare Holdings (No.4) Limited on 31 March 2023
15 May 2023 CH04 Secretary's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited on 31 March 2023
15 May 2023 CH02 Director's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited on 31 March 2023
02 Mar 2023 TM01 Termination of appointment of Brian James Mcnamara as a director on 1 March 2023
04 Jan 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Sweep dividend 12/07/2022
  • RES01 ‐ Resolution of adoption of Articles of Association
19 Dec 2022 PSC02 Notification of Haleon Intermediate Holdings Limited as a person with significant control on 15 December 2022
19 Dec 2022 PSC07 Cessation of Haleon Plc as a person with significant control on 15 December 2022
10 Oct 2022 CS01 Confirmation statement made on 27 September 2022 with updates
15 Aug 2022 CH01 Director's details changed for Mr Scott Christopher Bourgeois on 18 July 2022
29 Jul 2022 PSC07 Cessation of Pfizer Inc as a person with significant control on 17 July 2022
29 Jul 2022 PSC02 Notification of Haleon Plc as a person with significant control on 17 July 2022
21 Jul 2022 MA Memorandum and Articles of Association
20 Jul 2022 SH08 Change of share class name or designation
19 Jul 2022 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association